2021 Q4 Form 10-Q Financial Statement

#000164033421002931 Filed on November 22, 2021

View on sec.gov

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34279	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12539	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	15100	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	5792	USD
	us-gaap	Operating Expenses OperatingExpenses	34279	USD
	us-gaap	Operating Expenses OperatingExpenses	12539	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-15100	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-5792	USD
	us-gaap	Net Income Loss NetIncomeLoss	-34279	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12539	USD
CY2021Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
CY2021Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7705000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7705000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7705000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7705000	shares
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-96282	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-19179	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-115461	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-15100	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-130561	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-67562	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-6747	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-74309	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-80101	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	33920	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	12235	USD
	chc	Net Cash Used In Operating Activities NetCashUsedInOperatingActivities	-359	USD
	chc	Net Cash Used In Operating Activities NetCashUsedInOperatingActivities	-304	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	500	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	350	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	500	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	350	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	141	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	46	USD
	chc	Operating Expenses Paid By Related Party OperatingExpensesPaidByRelatedParty	9652	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1429	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1414	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1570	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1460	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	chc	Operating Expenses Paid By Related Party OperatingExpensesPaidByRelatedParty	26000	USD
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7705000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	75000000	shares
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7705000	shares
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15100	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5792	USD

Files In Submission

Name	View Source	Status
0001640334-21-002931-index-headers.html	Edgar Link	pending
0001640334-21-002931-index.html	Edgar Link	pending
0001640334-21-002931.txt	Edgar Link	pending
0001640334-21-002931-xbrl.zip	Edgar Link	pending
caro_10q.htm	Edgar Link	pending
caro_10q_htm.xml	Edgar Link	completed
caro_ex311.htm	Edgar Link	pending
caro_ex321.htm	Edgar Link	pending
chc-20210930.xsd	Edgar Link	pending
chc-20210930_cal.xml	Edgar Link	unprocessable
chc-20210930_def.xml	Edgar Link	unprocessable
chc-20210930_lab.xml	Edgar Link	unprocessable
chc-20210930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending